Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) Shares Outstanding (2016 - 2025)

Biomerica's Shares Outstanding history spans 15 years, with the latest figure at $2.9 million for Q4 2025.

  • For Q4 2025, Shares Outstanding fell 83.92% year-over-year to $2.9 million; the TTM value through Nov 2025 reached $2.9 million, down 83.92%, while the annual FY2025 figure was $2.5 million, 21.07% up from the prior year.
  • Shares Outstanding for Q4 2025 was $2.9 million at Biomerica, up from $2.8 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $20.4 million in Q1 2025 and bottomed at $2.1 million in Q2 2023.
  • The 5-year median for Shares Outstanding is $12.8 million (2021), against an average of $11.0 million.
  • The largest annual shift saw Shares Outstanding soared 3848.72% in 2021 before it plummeted 87.5% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $12.7 million in 2021, then grew by 6.2% to $13.5 million in 2022, then grew by 24.8% to $16.8 million in 2023, then rose by 9.01% to $18.3 million in 2024, then crashed by 83.92% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Shares Outstanding are $2.9 million (Q4 2025), $2.8 million (Q3 2025), and $2.5 million (Q2 2025).